← Back to headlines
ImmunityBio (IBRX) Receives FDA Warning, BTIG Maintains Positive Outlook
ImmunityBio (IBRX) has been issued a warning by the FDA, though investment firm BTIG has indicated it will maintain a positive stance on the company's prospects.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
50m ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
5h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
8h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
16h ago